Corbion stock falls 2.61 percent after CEO succession news

Published on 10/04/2026 at 09:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Corbion stock is tied to a CEO succession after Olivier Rigaud set May 12, 2027 as his mandate end. H1 sales fell to EUR 631.1 million, while margin guidance stays above 16%.

Aquarellbild von Amsterdamer Skyline und Grachtenhäusern bei Sonnenuntergang — Aquarellmalerei der Amsterdamer Skyline repräsentiert den Firmensitz von Corbion N.V. (ISIN NL0010583399) am Wasser, Illustration mit AI erstellt.

Corbion (ISIN NL0010583399) stock was last at EUR 21.60 on Euronext Amsterdam on October 2, 2026 at 5:35 p.m. CEST, down 2.61 percent from EUR 22.18. The latest catalyst was CEO Olivier Rigaud's decision not to seek a third term, a change that puts succession planning alongside the company's operating targets.

CEO succession adds a governance test

GlobeNewswire reported on October 2, 2026 that Rigaud will leave when his current mandate expires at the Annual General Meeting on May 12, 2027. Corbion's supervisory board has started the search for a successor and plans to propose Alexander Wessels for the supervisory board.

The timing matters because the leadership change arrives while Corbion is relying on better second-half execution to improve cash generation and margins. The 2.61 percent share-price decline on October 2, 2026 gives that governance update an immediate market signal, although the price remains inside its current 52-week range.

H1 figures set a tougher margin bar

According to Yahoo Finance in its H1 2026 earnings-call transcript, Corbion's sales fell 2.2 percent year over year to EUR 631.1 million in the first half of 2026, from EUR 645.6 million in H1 2025. Adjusted EBITDA declined 16.7 percent to EUR 88.8 million from EUR 106.6 million.

The quarterly trajectory was better: Q2 organic sales grew 8.5 percent to EUR 337.4 million, with adjusted EBITDA of EUR 51.0 million. Management maintained 2026 organic sales growth guidance of 3%-6% and refined adjusted EBITDA margin guidance to above 16%, making the second-half recovery a central test for the shares.

Barclays keeps a Hold view

Markets Insider reported that Barclays analyst Setu Sharda maintained a Hold rating on September 30, 2026, with a EUR 20.50 price target. That target sits below the October 2, 2026 reference price, while the stock's EUR 23.14 52-week high leaves the latest quote 6.7 percent below its yearly peak.

Stock remains below its yearly high

Corbion stock was last at EUR 21.60 on Euronext Amsterdam on October 2, 2026 at 5:35 p.m. CEST, with 163,893 shares traded and market capitalization of EUR 1.2 billion. The operating comparison and the CEO transition leave margin delivery and succession execution as the two clearest checkpoints for the shares.